Skip to main content

Botulinum Neurotoxins

  • Living reference work entry
  • First Online:
Encyclopedia of Molecular Pharmacology

Definition, Serotypes, and Subtypes

The botulinum neurotoxins (BoNTs) form a family of protein neurotoxins endowed with a set of particular properties that have made them powerful therapeutics for a variety of human syndromes. Their development as medicines is still undergoing. They are synthesized by different Clostridia though bacteria of other phyla may harbor the gene encoding for BoNTs. They consist of two chains (L, 50 kDa and H, 100 kDa) linked by a single interchain disulfide bond (Fig. 1a). They are produced in eight different serotypes (indicated by letters BoNT/A, /B, /C, /D, /E, /F, /G, and /X) (Rossetto et al. 2014; Dong et al. 2019). In addition many subtypes of a serotype are known (dubbed with a suffix number: BoNT/A1, BoNT/A2, etc.) plus chimeric neurotoxins (BoNT/CD, BoNT/DC, BoNT/FA). Thus, the BoNT family comprises several dozens of proteins, and their number is growing as result of massive DNA sequencing. None the less all BoNTs share a four-domain structure, with...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Dong M, Masuyer G, Stenmark P (2019) Botulinum and tetanus neurotoxins. Annu Rev Biochem 88:811–837

    Article  CAS  Google Scholar 

  • Erbguth FJ (2004) Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 19(8):S2–S6

    Article  Google Scholar 

  • Fleck-Derderian S, Shankar M, Rao AK, Chatham-Stephens K, Adjei S, Sobel J, Meltzer MI, Meaney-Delman D, Pillai SK (2017) The epidemiology of foodborne botulism outbreaks: a systematic review. Clin Infect Dis 66:S73–S81

    Article  Google Scholar 

  • Jankovic J (2018) An update on new and unique uses of botulinum toxin in movement disorders. Toxicon 147:84–88

    Article  CAS  Google Scholar 

  • Mazzocchio R, Caleo M (2015) More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system. Neuroscientist 21:44–61

    Article  Google Scholar 

  • Pirazzini M, Rossetto O, Eleopra R, Montecucco C (2017) Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev 69:200–235

    Article  CAS  Google Scholar 

  • Rossetto O, Pirazzini M, Montecucco C (2014) Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol 12:535–549

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The work in the authors’ laboratory was supported by the grant NIB-2 and RIPANE of the Ministry of Defence and from grants provided by the University of Padova.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cesare Montecucco .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Rossetto, O., Montecucco, C. (2020). Botulinum Neurotoxins. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_10014-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21573-6_10014-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21573-6

  • Online ISBN: 978-3-030-21573-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics